A Bitter Pill for Novo, Green Backlash Hits Orsted, Schneider Electric Down
On this episode of Stock Movers:- Novo Nordisk slumped after a pill from rival Eli Lilly helped patients shed weight and control blood sugar about as well as its injected blockbuster Ozempic. The stock dropped as much as 9.8% to 380 kroner early in Copenhagen, the first trading day since the Thursday announcement that buoyed Lilly.- The Trump administration halted work on an offshore wind farm being built off New York amid a broader review of the sector’s projects. The halt is the latest — and perhaps biggest — blow to a sector that seemed on the verge of major growth just…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.